QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 243 作者:  Liang, Xiaofei;  Wang, Chun;  Wang, Beilei;  Liu, Juan;  Qi, Shuang 收藏  |  浏览/下载：31/0  |  提交时间：2022/12/23 CSF1R inhibitor  Kinase inhibitor  Macrophage polarization   CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis 期刊论文 Molecular Cancer, 2022, 卷号: 21 作者:  Hua,Jinghan;  Wang,Xiaolin;  Ma,Liying;  Li,Jingxin;  Cao,Guozhen 收藏  |  浏览/下载：19/0  |  提交时间：2022/12/22 CircVAPA  SCLC  Progression  miR-377-3p  miR-494-3p  IGF1R  AKT  BMS-536924   Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles 期刊论文 Journal of Nanobiotechnology, 2022, 卷号: 20, 期号: 1, 页码: 20 作者:  Deng,Han;  Shang,Wenting;  Wang,Kun;  Guo,Kunxiong;  Liu,Yu 收藏  |  浏览/下载：22/0  |  提交时间：2022/06/06 Small hepatocellular carcinoma  Complex liver environment  Targeted detection  Dynamic contrast-enhanced photoacoustic imaging  Sequential catalysis-targeted therapy   CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang 收藏  |  浏览/下载：96/0  |  提交时间：2022/03/28 HER2  breast cancers  gastric cancers  irreversible inhibitor  drug resistance   GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Wang, Xiao-feng;  Hu, Can;  Mo, Shao-Wei;  Xu, Jing-Li;  Liu, Yan 收藏  |  浏览/下载：23/0  |  提交时间：2022/05/16